Venous Skin Ulcer Treatment Market by Type (Conservative Management, Mechanical Treatment, Surgical Management, Medications, Others) by End User (Hospital & Clinics, Home Care Settings, Long-Term Care Facilities, Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 24-Feb-2021 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5859 Status : Published

The venous skin ulcer treatment market is set for a rapid growth over the forecast period. In terms of revenue, the global venous skin ulcer treatment market accounted for USD 2,609.9 Million in 2019 and is expected to reach USD 3,815.5 Million by 2026, growing at a CAGR of 5.57%

Description

The venous skin ulcer treatment market is set for a rapid growth over the forecast period. In terms of revenue, the global venous skin ulcer treatment market accounted for USD 2,609.9 Million in 2019 and is expected to reach USD 3,815.5 Million by 2026, growing at a CAGR of 5.57%

Global Venous Skin Ulcer Treatment Market: Overview

The most common etiology of lower extremity ulceration is venous ulcer, also known as stasis ulcer, occurring in about 1% of the population in the United States. Inflammatory processes resulting in platelet aggregation, endothelial injury, leukocyte activation and intracellular edema are potential causes of venous ulcers. Increasing age, obesity, leg injuries, phlebitis, and deep venous thrombosis are the key risk factors for venous ulcer growth.

Venous ulcers are normally irregular, deep, and found over bony prominences when physically examined. In the ulcer base, granulation tissue and fibrin are normally present. The related effects include edema, lower extremity varicosities, lipodermatosclerosis, and venous dermatitis. Typically, venous ulcers are chronic, and open ulcers can remain for weeks to many years. Osteomyelitis, cellulitis and malignant changes are severe complications.

Large ulcer intensity and prolonged period are poor prognostic factors. Leg elevation, dressings, compression therapy, pentoxifylline, and aspirin therapy are evidence-based treatment choices for venous ulcers. For ulcers that are large in size, of extended length, or refractory to conservative measures, surgical management may be considered.

Global Venous Skin Ulcer Treatment Market: Growth Factors

The main factors involved in the development of venous leg ulcers are immobility, obesity, varicose veins, pregnancy, and past deep vein thrombosis. As a consequence, the prevalence of venous leg ulcers is increasingly growing. It is projected that an increase in incidence of venous leg ulcers will improve the global demand for venous skin ulcer treatment. For example, the occurrence of venous leg ulcers in the United States is about 600,000 yearly, as per an article published by the National Center for Biotechnology Information (NCBI). The increase in the geriatric population and the rise in the adoption of advanced wound dressings are also primary factors driving the demand for venous skin ulcer treatment.

The availability of various skin treatments and the increase in patient awareness and healthcare spending are important factors that further drive the global demand for venous skin ulcer treatment.

Impact due to the outbreak of COVID-19

Community service organizations took initiative to offer solutions for the treatment of venous skin ulcers in the midst of the coronavirus (COVID-19) pandemic. For example, the Tissue Viability Society, one of the UK's oldest community service organizations, has taken the steps to provide alternatives for venous skin ulcer treatment in the midst of the coronavirus epidemic by providing its official website with the relevant data on leg ulcer care. Increasing awareness of compression therapy products is accelerating revenue generation strategies for companies in the venous skin ulcer treatment market.

Since patients are seeking care for leg ulcer at home in the midst of the pandemic, companies in the treatment market for venous skin ulcer should improve their online sales and home delivery services to fulfill specific requirements for patients. The revenue from home care settings is therefore expected to rise rapidly in demand for the treatment of venous skin ulcers.

Global Venous Skin Ulcer Treatment Market: Segmentation

Compression therapy plays a crucial role in the prevention and recurrence of lower leg ulceration. There is, however, a lack of clear understanding of the preference of compression hosiery products to minimize venous skin ulcer recurrence. As a result, companies in the venous skin ulcer treatment industry are urging healthcare professionals to establish health programs that educate patients about the therapeutic benefits of compression hosiery products.

High rates of infection after healing have fueled the need for compression hosiery products in the venous skin ulcer treatment industry. This is obvious as the revenue from compression therapy products is expected to increase dramatically in the demand for venous skin ulcer treatment.

Improving skills of nursing workers results in improved uptake of wound dressings. For instance, community nursing teams are growing their emphasis in the Midlands, U.K., on managing venous leg ulcers effectively. Stakeholders who are part of the Midlands Partnership NHS Foundation Trust, for example, are providing a wide range of standardized evaluations by implementing the lower-limb evaluation algorithm for the treatment of venous skin ulcers.

Global Venous Skin Ulcer Treatment Market: Regional Analysis

By Geography, the venous skin ulcer treatment market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

North America dominated the global market for venous skin ulcer treatment in 2019 due to the rising prevalence of chronic wounds, a better reimbursement scenario, and early acceptance of advanced products in the region. For example, according to Centers for Disease Control and Prevention (CDC) report, about 2.5 million patients in the U.S. struggle from pressure ulcers every year.

The market in Asia Pacific is expected to expand at a significant CAGR during the forecast period due to a rise in the geriatric population, the advent of strong local manufacturers providing technologically advanced products at lower prices, and an increase in public awareness of early treatment of chronic wounds.

Global Venous Skin Ulcer Treatment Market: Competitive Players

The major players in the global venous skin ulcer treatment market include Integra LifeSciences Corporation, Smith & Nephew plc., Mölnlycke Health Care AB, 3M, Cardinal Health, URGO Medical, PAUL HARTMANN AG, Bauerfeind, and SIGVARIS among others

The report segment of global venous skin ulcer treatment market are as follows:

Global Venous Skin Ulcer Treatment Market: Type Segment Analysis

  • Conservative Management
  • Mechanical Treatment
  • Surgical Management
  • Medications
  • Others

Global Venous Skin Ulcer Treatment Market: End User Segment Analysis

  • Hospital & Clinics
  • Home Care Settings
  • Long-Term Care Facilities
  • Others

Global Venous Skin Ulcer Treatment Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description
      • 1.1.1. Objective
      • 1.1.2. Target Audience
      • 1.1.3. Unique Selling Proposition (USP) & Offerings
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
      • 1.3.3. Level 1: Primary Research
      • 1.3.4. Level 2: Secondary Research
      • 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
  • Chapter 2. Executive Summary
    • 2.1. Global Venous Skin Ulcer Treatment Market, 2016-2026, (USD Million)
    • 2.2. Venous Skin Ulcer Treatment Market: Market snapshot
  • Chapter 3. Global Venous Skin Ulcer Treatment Market – Industry Analysis
    • 3.1. Introduction
    • 3.2. Industry ecosystem analysis
    • 3.3. Technulogy landscape
    • 3.4. Market Drivers
      • 3.4.1. North America
      • 3.4.2. Europe
      • 3.4.3. Asia Pacific
      • 3.4.4. Latin America
      • 3.4.5. MEA
    • 3.5. Restraints
    • 3.6. Opportunity
    • 3.7. Innovation & sustainability
    • 3.8. Regulatory landscape
    • 3.9. Porter’s Five Forces Analysis
    • 3.10. PESTLE Analysis
    • 3.11. Venous Skin Ulcer Treatment Market: Market Attractiveness Analysis
      • 3.11.1. Market Attractiveness Analysis by Type Segment
      • 3.11.2. Market Attractiveness Analysis by End User Segment
  • Chapter 4. Global Venous Skin Ulcer Treatment Market - Competitive Landscape
    • 4.1. Company Market Share Analysis, 2019
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions and Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Cullaborations and Joint Ventures
      • 4.2.4. Research & Development and Regional Expansion
  • Chapter 5. Venous Skin Ulcer Treatment Market – Type Segment Analysis
    • 5.1. Global Venous Skin Ulcer Treatment Market Revenue Share, by Type, 2019 & 2026 (USD Million)
    • 5.2. Global Venous Skin Ulcer Treatment Market by Conservative Management, 2016 – 2026 (USD Million)
    • 5.3. Global Venous Skin Ulcer Treatment Market by Mechanical Treatment, 2016 – 2026 (USD Million)
    • 5.4. Global Venous Skin Ulcer Treatment Market by Surgical Management, 2016 – 2026 (USD Million)
    • 5.5. Global Venous Skin Ulcer Treatment Market by Medications, 2016 – 2026 (USD Million)
    • 5.6. Global Venous Skin Ulcer Treatment Market by Others, 2016 – 2026 (USD Million)
  • Chapter 6. Venous Skin Ulcer Treatment Market – End User Segment Analysis
    • 6.1. Global Venous Skin Ulcer Treatment Market Revenue Share, by End User, 2019 & 2026 (USD Million)
    • 6.2. Global Venous Skin Ulcer Treatment Market by Hospital & Clinics, 2016 – 2026 (USD Million)
    • 6.3. Global Venous Skin Ulcer Treatment Market by Home Care Settings, 2016 – 2026 (USD Million)
    • 6.4. Global Venous Skin Ulcer Treatment Market by Long-Term Care Facilities, 2016 – 2026 (USD Million)
    • 6.5. Global Venous Skin Ulcer Treatment Market by Others, 2016 – 2026 (USD Million)
  • Chapter 7. Venous Skin Ulcer Treatment Market - Regional Analysis
    • 7.1. Global Venous Skin Ulcer Treatment Market: Regional Overview
      • 7.1.1. Global Venous Skin Ulcer Treatment Market Revenue Share, By Region, 2019 & 2026 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Venous Skin Ulcer Treatment Market Revenue 2016 – 2026 (USD Million)
      • 7.2.2. North America Venous Skin Ulcer Treatment Market Revenue, By Type, 2016 – 2026 (USD Million)
      • 7.2.3. North America Venous Skin Ulcer Treatment Market Revenue, By End User, 2016 – 2026 (USD Million)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.2.4.2. U.S. Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.2.5. Canada
        • 7.2.5.1. Canada Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.2.5.2. Canada Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.2.6. Mexico
        • 7.2.6.1. Mexico Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.2.6.2. Mexico Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Venous Skin Ulcer Treatment Market Revenue 2016 – 2026 (USD Million)
      • 7.3.2. Europe Venous Skin Ulcer Treatment Market Revenue, By Type, 2016 – 2026 (USD Million)
      • 7.3.3. Europe Venous Skin Ulcer Treatment Market Revenue, By End User, 2016 – 2026 (USD Million)
      • 7.3.4. UK
        • 7.3.4.1. UK Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.3.4.2. UK Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.3.5.2. France Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.3.6.2. Germany Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.3.7. Italy
        • 7.3.7.1. Italy Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.3.7.2. Italy Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.3.8. Spain
        • 7.3.8.1. Spain Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.3.8.2. Spain Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.3.9. Russia
        • 7.3.9.1. Russia Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.3.9.2. Russia Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.3.10.2. Rest of Europe Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Venous Skin Ulcer Treatment Market Revenue 2016 – 2026 (USD Million)
      • 7.4.2. Asia Pacific Venous Skin Ulcer Treatment Market Revenue, By Type, 2016 – 2026 (USD Million)
      • 7.4.3. Asia Pacific Venous Skin Ulcer Treatment Market Revenue, By End User, 2016 – 2026 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.4.4.2. China Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.4.5.2. Japan Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.4.6.2. India Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.4.7. Australia
        • 7.4.7.1. Australia Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.4.7.2. Australia Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.4.8.2. South Korea Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.4.9. Rest of Asia Pacific
        • 7.4.9.1. Rest of Asia Pacific Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.4.9.2. Rest of Asia Pacific Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Venous Skin Ulcer Treatment Market Revenue 2016 – 2026 (USD Million)
      • 7.5.2. Latin America Venous Skin Ulcer Treatment Market Revenue, By Type, 2016 – 2026 (USD Million)
      • 7.5.3. Latin America Venous Skin Ulcer Treatment Market Revenue, By End User, 2016 – 2026 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.5.4.2. Brazil Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.5.5. Argentina
        • 7.5.5.1. Argentina Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.5.5.2. Argentina Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.5.6. Rest of Latin America
        • 7.5.6.1. Rest of Latin America Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.5.6.2. Rest of Latin America Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
    • 7.6. Middle East & Africa
      • 7.6.1. Middle East & Africa Venous Skin Ulcer Treatment Market Revenue 2016 – 2026 (USD Million)
      • 7.6.2. Middle East & Africa Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
      • 7.6.3. Middle East & Africa Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.6.4. GCC Countries
        • 7.6.4.1. GCC Countries Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.6.4.2. GCC Countries Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
      • 7.6.5. South Africa
        • 7.6.5.1. South Africa Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 7.6.5.2. South Africa Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
          • 7.6.5.2.1.1. Rest of MEA
      • 7.6.5.3. Rest of MEA Venous Skin Ulcer Treatment Market Revenue, by Type, 2016 – 2026 (USD Million)
      • 7.6.5.4. Rest of MEA Venous Skin Ulcer Treatment Market Revenue, by End User, 2016 – 2026 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Integra LifeSciences Corporation
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfulio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. *Same information will be provided for below mentioned companies*
      • 8.2.1. Smith & Nephew plc.
      • 8.2.2. Mölnlycke Health Care AB
      • 8.2.3. 3M
      • 8.2.4. Cardinal Health
      • 8.2.5. URGO Medical
      • 8.2.6. PAUL HARTMANN AG
      • 8.2.7. Bauerfeind
      • 8.2.8. SIGVARIS
      • 8.2.9. Others

Methodology


Frequently Asked Questions

The main factors involved in the development of venous leg ulcers are immobility, obesity, varicose veins, pregnancy, and past deep vein thrombosis. As a consequence, the prevalence of venous leg ulcers is increasingly growing. It is projected that an increase in incidence of venous leg ulcers will improve the global demand for venous skin ulcer treatment. For example, the occurrence of venous leg ulcers in the United States is about 600,000 yearly, as per an article published by the National Center for Biotechnology Information (NCBI). The increase in the geriatric population and the rise in the adoption of advanced wound dressings are also primary factors driving the demand for venous skin ulcer treatment. The availability of various skin treatments and the increase in patient awareness and healthcare spending are important factors that further drive the global demand for venous skin ulcer treatment.

According to Zion Market Research, the Venous Skin Ulcer Treatment market is expected to generate revenue of around USD 3,815.5 Million by the end of 2026, growing at a CAGR of 5.57%.

North America dominated the global market for venous skin ulcer treatment in 2019 due to the rising prevalence of chronic wounds, a better reimbursement scenario, and early acceptance of advanced products in the region. For example, according to Centers for Disease Control and Prevention (CDC) report, about 2.5 million patients in the U.S. struggle from pressure ulcers every year. The market in Asia Pacific is expected to expand at a significant CAGR during the forecast period due to a rise in the geriatric population, the advent of strong local manufacturers providing technologically advanced products at lower prices, and an increase in public awareness of early treatment of chronic wounds.

The major players in the global venous skin ulcer treatment market include Integra LifeSciences Corporation, Smith & Nephew plc., Mölnlycke Health Care AB, 3M, Cardinal Health, URGO Medical, PAUL HARTMANN AG, Bauerfeind, and SIGVARIS among others

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com